RISPERDAL and Risperidone Tablets recalled due to odor of TBA

by Anil Kumar



Ortho-McNeil-Janssen Pharmaceuticals, Inc. is initiating a voluntary recall of one lot of RISPERDAL® (risperidone) 3mg Tablets, marketed by Janssen Division of Ortho-McNeil-Janssen Pharmaceuticals, Inc. and one lot of risperidone 2mg Tablets, marketed by Patriot Pharmaceuticals, LLC, a wholly owned subsidiary of Ortho-McNeil-Janssen Pharmaceuticals, Inc.

The recalls stem from two consumer reports of an uncharacteristic odor thought to be caused by trace amounts of TBA (2,4,6 tribromoanisole).

TBA is a byproduct of a chemical preservative sometimes applied to wood often used in the construction of pallets on which materials are transported and stored. In January 2010, the company instituted a number of actions to reduce the potential of TBA contamination, including requiring suppliers to certify that they do not use pallets made from chemically-treated wood.

While not considered to be toxic, TBA can generate an offensive odor and a very small number of patients have reported temporary gastrointestinal symptoms when taking other products with this odor. As it relates to RISPERDAL® and risperidone, there have been no reported serious adverse events caused by the presence of TBA.

RISPERDAL® (risperidone) is used for the treatment of schizophrenia in adults and adolescents ages 13-17 years.

RISPERDAL® (risperidone) is used alone or in combination with other medicines (valproate or lithium) in adults for the short-term treatment of bipolar mania; or alone in adults, children and adolescents ages 10-17 years for the short-term treatment of bipolar mania.

RISPERDAL® (risperidone) is used for the treatment of irritability associated with autistic disorder in children and adolescents ages 5-16 years.

Ortho-McNeil-Janssen Pharmaceuticals, Inc. has initiated these recalls in the U.S. and Puerto Rico at the wholesale and retail (pharmacy) level and is communicating this information to these customers. The company does not anticipate a product shortage resulting from this action.

Patients should not stop taking their medication. Anyone experiencing an uncharacteristic odor associated with RISPERDAL® 3mg Tablets or risperidone 2mg Tablets should return the tablets to their pharmacist, and contact their healthcare professional if they have questions. Patients or healthcare professionals can contact the Medical Information Recall Line at 1-800-634-8977 (Monday – Friday, 9 am – 5 pm ET).


(Anil Kumar -- sub-editor compiled and published RISPERDAL and Risperidone Tablets recalled due to odor of TBA at HealthNewsTrack on June 19, 2011 sourced from Johnson & Johnson - http://www.jnj.com/)

Schizophrenia - recent articles and current news stories:

- Antipsychotic drugs may lead to brain loss in schizophrenia patients
- Immune responses during pregnancy linked to schizophrenia among offspring
- Blood flows differently through the brains of schizophrenic patients
- Schizophrenia linked to common genetic variations

Most related articles:

- RISPERDAL and Risperidone Tablets recalled due to odor of TBA
- Risperdal Consta approved for bipolar disorder - 9.3
- Pfizer recalls Lo Ovral 28 And Norgestrel Ethinyl Estradiol Tablets - 6.2
- Duragesic 25 mcg/hr CII pain patches recalled - 4.8
- FDA and CDC recommendations for consumers using peanut products - 4.6

More related articles:

- RISPERDAL, Risperidone, TBA, Tribromoanisole, Schizophrenia, Bipolar mania, Autistic disorder
- Risperdal Consta approved for bipolar disorder - 20.6
- Role of Omega-3 unclear for bipolar disorder - 12.2
- Complete Response Letter on Seroquel XR for major depressive disorder - 11.8
- Study to pinpoint bipolar disorder risk factors - 9.7

Schizophrenia related articles:

- Cancer - a concern in schizophrenia patients - 5.4
- Substance abuse increases crime risk in schizophrenia patients - 5.4
- Chromosomal changes increase schizophrenia risk - 5.2
- Fanapt iloperidone approved for schizophrenia treatment - 4.6
- Schizophrenia linked to common genetic variations - 4.5

Schizophrenia article/news source:

Read more health articles from Johnson & Johnson and health articles from USA.

Schizophrenia - search related terms:

Autistic disorder, Bipolar mania, RISPERDAL, Risperidone, Schizophrenia, TBA, Tribromoanisole,
Schizophrenia books,

Searched keywords: l (12),

List health news, Health organizations, Health news world, Glossary, Best health articles, Featured     Go to top

The information provided on Health Newstrack is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician. We comply with the HONcode principles for trustworthy health information, and Health News Track is hon code accredited, verify here.
About us, Site map Privacy policy, Disclaimer
© 2007, 2008, 2009, 2010, 2011 HealthNewsTrack.com
11.24